Transcend Wealth Collective, LLC
- SEC CIK
- 0001776082
- Latest filing
- Aug 4, 2026
OTLK holding history
Outlook Therapeutics, Inc. in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q2 2023 | 10,000 | $17.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,000 | $10.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,000 | $10.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,000 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,000 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,000 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,000 | $14.0K | <0.1% | +10,000 | New | Holders |